Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.42%

Novavax, Inc. (NVAX)

-NasdaqGS
5.62 Down 0.16(2.77%) May 26, 4:00PM EDT
|After Hours : 5.62 0.00 (0.00%) May 26, 7:59PM EDT
Prev Close:5.78
Open:5.77
Bid:5.60 x 2000
Ask:5.83 x 800
1y Target Est:14.21
Beta:1.82711
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:5.57 - 5.78
52wk Range:4.08 - 15.01
Volume:3,795,451
Avg Vol (3m):5,725,680
Market Cap:1.52B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NVAXDown 2.77%1.52B
MRKDown 0.32%156.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.96
Quarterly EPS Est (Jun-16) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback